Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

An evaluation of 6-month versus continuous isoniazid preventive therapy for M. tuberculosis in adults living with HIV/AIDS in Malawi.
Hsieh, YL; Jahn, A; Menzies, NA; Yaesoubi, R; Salomon, JA; Girma, B; Gunde, L; Eaton, JW; Auld, A; Odo, M; Kiyiika, CN; Kalua, T; Chiwandira, B; Mpunga, JU; Mbendra, K; CORBETT, L; Hosseinipour, MC; Cohen, T; Kunkel, A;
2020
Journal of acquired immune deficiency syndromes (1999) (2020). 10.1097/qai.0000000000002497.
A blood RNA transcript signature for TB exposure in household contacts.
Kwan, PK W; Periaswamy, B; De Sessions, PF; Lin, W; Molton, JS; Naftalin, CM; Naim, AN M; HIBBERD, ML; Paton, NI;
2020
BMC INFECTIOUS DISEASES, (2020).20 1 10.1186/s12879-020-05116-1.
Extrapulmonary tuberculosis among migrants in Europe, 1995 to 2017.
HAYWARD, SE; Rustage, K; Nellums, LB; Van der Werf, MJ; Noori, T; BOCCIA, D; Friedland, JS; Hargreaves, S;
2020
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, (2020).27 9 10.1016/j.cmi.2020.12.006.
Longitudinal Pharmacokinetic-Pharmacodynamic Biomarkers Correlate With Treatment Outcome in Drug-Sensitive Pulmonary Tuberculosis: A Population Pharmacokinetic-Pharmacodynamic Analysis.
Kloprogge, F; Mwandumba, HC; Banda, G; Kamdolozi, M; Shani, D; CORBETT, EL; Kontogianni, N; Ward, S; Khoo, SH; Davies, GR; Sloan, DJ;
2020
OPEN FORUM INFECTIOUS DISEASES, (2020).7 7 10.1093/ofid/ofaa218.
Impact of Intermediate Hyperglycemia and Diabetes on Immune Dysfunction in Tuberculosis.
Eckold, C; Kumar, V; Weiner, J; Alisjahbana, B; Riza, A-L; Ronacher, K; Coronel, J; Kerry-Barnard, S; Malherbe, ST; Kleynhans, L; Stanley, K; Ruslami, R; Ioana, M; Ugarte-Gil, C; Walzl, G; Van Crevel, R; Wijmenga, C; Critchley, JA; DOCKRELL, HM; CLIFF, JM; TANDEM consortium,;
2020
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (2020).72 1 10.1093/cid/ciaa751.
Robust barcoding and identification of Mycobacterium tuberculosis lineages for epidemiological and clinical studies.
Napier, G; CAMPINO, S; Merid, Y; Abebe, M; Woldeamanuel, Y; Aseffa, A; HIBBERD, ML; PHELAN, J; CLARK, TG;
2020
GENOME MEDICINE, (2020).12 1 10.1186/s13073-020-00817-3.
All nonadherence is equal but is some more equal than others? Tuberculosis in the digital era.
STAGG, HR; Flook, M; Martinecz, A; Kielmann, K; Abel Zur Wiesch, P; KARAT, AS; Lipman, MC I; Sloan, DJ; Walker, EF; FIELDING, KL;
2020
ERJ Open Research, (2020).6 4 10.1183/23120541.00315-2020.
The potential impact of COVID-19-related disruption on tuberculosis burden.
MCQUAID, CF; MCCREESH, N; Read, JM; SUMNER, T; CMMID COVID-19 Working Group,; HOUBEN, RM G J; WHITE, RG; Harris, RC;
2020
The European respiratory journal, (2020).56 2 10.1183/13993003.01718-2020.
National tuberculosis prevalence surveys in Africa, 2008-2016: an overview of results and lessons learned.
Law, I; Floyd, K; African TB Prevalence Survey Group,;
2020
Tropical medicine & international health, (2020).25 11 10.1111/tmi.13485.
Estimating the Impact of Tuberculosis Case Detection in Constrained Health Systems: An Example of Case-Finding in South Africa.
SUMNER, T; BOZZANI, F; Mudzengi, D; Hippner, P; HOUBEN, RM; Cardenas, V; VASSALL, A; WHITE, RG;
2019
American journal of epidemiology, (2019).188 6 10.1093/aje/kwz038.